Effective June 4, 2014, Chembio, Medford, NY, has announced the launch of its United States sales and marketing effort for its HIV 1/2 Stat-Pak assay and related HIV Rapid Test Control Pack, along with the company's DPP HIV 1/2 assay and corresponding DPP HIV 1/2 Control Pack. The Stat-Pak assay was previously marketed in the US as the Clearview HIV 1/2 Stat-Pak assay, available through Alere. The HIV 1/2 Stat-Pak assay is FDA-approved and CLIA-waived. According to the company, it has been one of the leading diagnostics used for HIV/AIDS since its market introduction in 2006. The test's ease of use, 5-µL specimen requirement, rapid results, long shelf life, and room temperature storage make it suitable for clinical and outreach settings, allowing immediate patient counseling and referral.